IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53.

about

IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53.

Item

http://www.wikidata.org/entity/Q55457146

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53.

@en

IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53.

@nl

type

Item

label

IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53.

@en

IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53.

@nl

prefLabel

IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53.

@en

IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53.

@nl

P1476

IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53

@en

P2093

Ai Chen

http://www.w3.org/2001/XMLSchema#string

Bin Jiang

http://www.w3.org/2001/XMLSchema#string

Cong Ouyang

http://www.w3.org/2001/XMLSchema#string

Furong Lin

http://www.w3.org/2001/XMLSchema#string

Huamin Zhou

http://www.w3.org/2001/XMLSchema#string

Huihui Wang

http://www.w3.org/2001/XMLSchema#string

Jia Zhang

http://www.w3.org/2001/XMLSchema#string

Jinyang Wang

http://www.w3.org/2001/XMLSchema#string

Lin Zhou

http://www.w3.org/2001/XMLSchema#string

Mengjue Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

Recurring mutations found by sequencing an acute myeloid leukemia genome

An integrated genomic analysis of human glioblastoma multiforme

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases

P304

9747-9758

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.RA117.001385

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

293

http://www.w3.org/2001/XMLSchema#string

P50

Huanhuan Ma

P577

2018-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29743236

http://www.w3.org/2001/XMLSchema#string

P932

6016470

http://www.w3.org/2001/XMLSchema#string